{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:26:58Z","timestamp":1793604418388,"version":"4.5.0"},"reference-count":82,"publisher":"Journal of Biomedical Research","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Biomed Res"],"published-print":{"date-parts":[[2026]]},"DOI":"10.7555\/jbr.39.20250499","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T13:34:52Z","timestamp":1775309692000},"page":"1","source":"Crossref","is-referenced-by-count":1,"title":["Potential crosstalk between Parkinson's disease and glucose metabolism"],"prefix":"10.7555","volume":"40","author":[{"given":"Yafang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongjie","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4380","reference":[{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.1","doi-asserted-by":"publisher","unstructured":"Tolosa E, Garrido A, Scholz SW, et al. Challenges in the diagnosis of Parkinson's disease[J]. <i>Lancet Neurol<\/i>, 2021, 20(5): 385\u2013397.","DOI":"10.1016\/S1474-4422(21)00030-2"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.2","doi-asserted-by":"publisher","unstructured":"Yu H, Chang Q, Sun T, et al. Metabolic reprogramming and polarization of microglia in Parkinson's disease: Role of inflammasome and iron[J]. <i>Ageing Res Rev<\/i>, 2023, 90: 102032.","DOI":"10.1016\/j.arr.2023.102032"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.3","doi-asserted-by":"publisher","unstructured":"Dai C, Tan C, Zhao L, et al. Glucose metabolism impairment in Parkinson's disease[J]. <i>Brain Res Bull<\/i>, 2023, 199: 110672.","DOI":"10.1016\/j.brainresbull.2023.110672"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.4","doi-asserted-by":"publisher","unstructured":"Dienel GA. Brain glucose metabolism: Integration of energetics with function[J]. <i>Physiol Rev<\/i>, 2019, 99(1): 949\u20131045.","DOI":"10.1152\/physrev.00062.2017"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.5","doi-asserted-by":"publisher","unstructured":"Naeem U, Arshad AR, Jawed A, et al. Glycolysis: The next big breakthrough in Parkinson's disease[J]. <i>Neurotox Res<\/i>, 2022, 40(6): 1707\u20131717.","DOI":"10.1007\/s12640-022-00579-3"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.6","doi-asserted-by":"publisher","unstructured":"Yan S, Zhao X, Si Y, et al. Metabolic landscape uncovers remodeling of T cell immunity affected by fatty acid desaturase in Parkinson's disease at single-cell resolution[J]. <i>BMC Biol<\/i>, 2025, 23(1): 245.","DOI":"10.1186\/s12915-025-02358-w"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.7","doi-asserted-by":"publisher","unstructured":"Mergenthaler P, Lindauer U, Dienel GA, et al. Sugar for the brain: The role of glucose in physiological and pathological brain function[J]. <i>Trends Neurosci<\/i>, 2013, 36(10): 587\u2013597.","DOI":"10.1016\/j.tins.2013.07.001"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.8","doi-asserted-by":"publisher","unstructured":"Zhang S, Lachance BB, Mattson MP, et al. Glucose metabolic crosstalk and regulation in brain function and diseases[J]. <i>Prog Neurobiol<\/i>, 2021, 204: 102089.","DOI":"10.1016\/j.pneurobio.2021.102089"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.9","doi-asserted-by":"publisher","unstructured":"Cunnane SC, Trushina E, Morland C, et al. Brain energy rescue: An emerging therapeutic concept for neurodegenerative disorders of ageing[J]. <i>Nat Rev Drug Discov<\/i>, 2020, 19(9): 609\u2013633.","DOI":"10.1038\/s41573-020-0072-x"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.10","doi-asserted-by":"publisher","unstructured":"Muraleedharan R, Gawali MV, Tiwari D, et al. AMPK-regulated astrocytic lactate shuttle plays a non-cell-autonomous role in neuronal survival[J]. <i>Cell Rep<\/i>, 2020, 32(9): 108092.","DOI":"10.1016\/j.celrep.2020.108092"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.11","doi-asserted-by":"publisher","unstructured":"Wang L, Pavlou S, Du X, et al. Glucose transporter 1 critically controls microglial activation through facilitating glycolysis[J]. <i>Mol Neurodegener<\/i>, 2019, 14(1): 2.","DOI":"10.1186\/s13024-019-0305-9"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.12","doi-asserted-by":"publisher","unstructured":"Bell SM, Burgess T, Lee J, et al. Peripheral glycolysis in neurodegenerative diseases[J]. <i>Int J Mol Sci<\/i>, 2020, 21(23): 8924.","DOI":"10.3390\/ijms21238924"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.13","doi-asserted-by":"publisher","unstructured":"Chen J, Li G, Sun D, et al. Research progress of hexokinase 2 in inflammatory-related diseases and its inhibitors[J]. <i>Eur J Med Chem<\/i>, 2024, 264: 115986.","DOI":"10.1016\/j.ejmech.2023.115986"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.14","doi-asserted-by":"publisher","unstructured":"Almeida A, Jimenez-Blasco D, Bola\u00f1os JP. Cross-talk between energy and redox metabolism in astrocyte-neuron functional cooperation[J]. <i>Essays Biochem<\/i>, 2023, 67(1): 17\u201326.","DOI":"10.1042\/EBC20220075"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.15","doi-asserted-by":"publisher","unstructured":"Chen L, Wang C, Qin L, et al. Parkinson's disease and glucose metabolism impairment[J]. <i>Transl Neurodegener<\/i>, 2025, 14(1): 10.","DOI":"10.1186\/s40035-025-00467-8"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.16","doi-asserted-by":"publisher","unstructured":"Ioannou MS, Jackson J, Sheu SH, et al. Neuron-astrocyte metabolic coupling protects against activity-induced fatty acid toxicity[J]. <i>Cell,<\/i> 2019, 177(6): 1522\u20131535.e14.","DOI":"10.1016\/j.cell.2019.04.001"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.17","doi-asserted-by":"publisher","unstructured":"Bonvento G, Bola\u00f1os JP. Astrocyte-neuron metabolic cooperation shapes brain activity[J]. <i>Cell Metab<\/i>, 2021, 33(8): 1546\u20131564.","DOI":"10.1016\/j.cmet.2021.07.006"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.18","doi-asserted-by":"publisher","unstructured":"Morrone Parfitt G, Coccia E, Goldman C, et al. Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset Parkinson's disease model[J]. <i>Nat Commun<\/i>, 2024, 15(1): 447.","DOI":"10.1038\/s41467-024-44732-2"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.19","doi-asserted-by":"publisher","unstructured":"Wei Y, Miao Q, Zhang Q, et al. Aerobic glycolysis is the predominant means of glucose metabolism in neuronal somata, which protects against oxidative damage[J]. <i>Nat Neurosci<\/i>, 2023, 26(12): 2081\u20132089.","DOI":"10.1038\/s41593-023-01476-4"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.20","doi-asserted-by":"publisher","unstructured":"Halim ND, Mcfate T, Mohyeldin A, et al. Phosphorylation status of pyruvate dehydrogenase distinguishes metabolic phenotypes of cultured rat brain astrocytes and neurons[J]. <i>Glia<\/i>, 2010, 58(10): 1168\u20131176.","DOI":"10.1002\/glia.20996"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.21","doi-asserted-by":"publisher","unstructured":"Herrero-Mendez A, Almeida A, Fern\u00e1ndez E, et al. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC\/C-Cdh1[J]. <i>Nat Cell Biol<\/i>, 2009, 11(6): 747\u2013752.","DOI":"10.1038\/ncb1881"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.22","doi-asserted-by":"publisher","unstructured":"Zhang Y, Chen K, Sloan SA, et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex[J]. <i>J Neurosci<\/i>, 2014, 34(36): 11929\u201311947.","DOI":"10.1523\/JNEUROSCI.1860-14.2014"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.23","doi-asserted-by":"publisher","unstructured":"de Rus Jacquet A, Tancredi JL, Lemire AL, et al. The LRRK2 G2019S mutation alters astrocyte-to-neuron communication <i>via<\/i> extracellular vesicles and induces neuron atrophy in a human iPSC-derived model of Parkinson's disease[J]. <i>eLife<\/i>, 2021, 10: e73062.","DOI":"10.7554\/eLife.73062"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.24","doi-asserted-by":"publisher","unstructured":"Pellerin L, Magistretti PJ. Glutamate uptake into astrocytes stimulates aerobic glycolysis: A mechanism coupling neuronal activity to glucose utilization[J]. <i>Proc Natl Acad Sci U S A<\/i>, 1994, 91(22): 10625\u201310629.","DOI":"10.1073\/pnas.91.22.10625"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.25","doi-asserted-by":"publisher","unstructured":"B\u00e9langer M, Allaman I, Magistretti PJ. Brain energy metabolism: Focus on astrocyte-neuron metabolic cooperation[J]. <i>Cell Metab<\/i>, 2011, 14(6): 724\u2013738.","DOI":"10.1016\/j.cmet.2011.08.016"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.26","doi-asserted-by":"publisher","unstructured":"Braga A, Chiacchiaretta M, Pellerin L, et al. Astrocytic metabolic control of orexinergic activity in the lateral hypothalamus regulates sleep and wake architecture[J]. <i>Nat Commun<\/i>, 2024, 15(1): 5979.","DOI":"10.1038\/s41467-024-50166-7"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.27","doi-asserted-by":"publisher","unstructured":"Kang BS, Choi BY, Kho AR, et al. Effects of pyruvate kinase M2 (PKM2) gene deletion on astrocyte-specific glycolysis and global cerebral ischemia-induced neuronal death[J]. <i>Antioxidants (Basel)<\/i>, 2023, 12(2): 491.","DOI":"10.3390\/antiox12020491"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.28","doi-asserted-by":"publisher","unstructured":"Cha H, Choi JH, Jeon H, et al. Aquaporin-4 deficiency is associated with cognitive impairment and alterations in astrocyte-neuron lactate shuttle[J]. <i>Mol Neurobiol<\/i>, 2023, 60(11): 6212\u20136226.","DOI":"10.1007\/s12035-023-03475-9"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.29","doi-asserted-by":"publisher","unstructured":"M\u00fcller MS, Fouyssac M, Taylor CW. Effective glucose uptake by human astrocytes requires its sequestration in the endoplasmic reticulum by glucose-6-phosphatase-\u03b2[J]. <i>Curr Biol<\/i>, 2018, 28(21): 3481\u20133486.e4.","DOI":"10.1016\/j.cub.2018.08.060"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.30","doi-asserted-by":"publisher","unstructured":"de Tredern E, Rabah Y, Pasquer L, et al. Glial glucose fuels the neuronal pentose phosphate pathway for long-term memory[J]. <i>Cell Rep<\/i>, 2021, 36(8): 109620.","DOI":"10.1016\/j.celrep.2021.109620"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.31","doi-asserted-by":"publisher","unstructured":"Gao L, Liu F, Hou P, et al. Neurons release injured mitochondria as \"help-me\" signaling after ischemic stroke[J]. <i>Front Aging Neurosci<\/i>, 2022, 14: 785761.","DOI":"10.3389\/fnagi.2022.785761"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.32","doi-asserted-by":"publisher","unstructured":"Hayakawa K, Esposito E, Wang X, et al. Transfer of mitochondria from astrocytes to neurons after stroke[J]. <i>Nature<\/i>, 2016, 535(7613): 551\u2013555.","DOI":"10.1038\/nature18928"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.33","doi-asserted-by":"publisher","unstructured":"Ni X, Wang H, Cai Y, et al. Ginsenoside Rb1 inhibits astrocyte activation and promotes transfer of astrocytic mitochondria to neurons against ischemic stroke[J]. <i>Redox Biol<\/i>, 2022, 54: 102363.","DOI":"10.1016\/j.redox.2022.102363"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.34","doi-asserted-by":"publisher","unstructured":"Zhou J, Zhang L, Peng J, et al. Astrocytic LRP1 enables mitochondria transfer to neurons and mitigates brain ischemic stroke by suppressing ARF1 lactylation[J]. <i>Cell Metab<\/i>, 2024, 36(9): 2054\u20132068.e14.","DOI":"10.1016\/j.cmet.2024.05.01"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.35","doi-asserted-by":"publisher","unstructured":"Su X, Zhang D, Zhang N. Chrysophanol accelerates astrocytic mitochondria transfer to neurons and attenuates the cerebral ischemia-reperfusion injury in rats[J]. <i>Biochem Biophys Res Commun<\/i>, 2024, 704: 149712.","DOI":"10.1016\/j.bbrc.2024.149712"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.36","doi-asserted-by":"publisher","unstructured":"\u00d6hman A, Forsgren L. NMR metabonomics of cerebrospinal fluid distinguishes between Parkinson's disease and controls[J]. <i>Neurosci Lett<\/i>, 2015, 594: 36\u201339.","DOI":"10.1016\/j.neulet.2015.03.051"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.37","doi-asserted-by":"publisher","unstructured":"Meles SK, Renken RJ, Pagani M, et al. Abnormal pattern of brain glucose metabolism in Parkinson's disease: Replication in three European cohorts[J]. <i>Eur J Nucl Med Mol Imaging<\/i>, 2020, 47(2): 437\u2013450.","DOI":"10.1007\/s00259-019-04570-7"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.38","doi-asserted-by":"publisher","unstructured":"Oh JY, An EJ, Lee Y, et al. Association of dysphagia with altered brain glucose metabolism in Parkinson's disease[J]. <i>CNS Neurosci Ther<\/i>, 2023, 29(9): 2498\u20132507.","DOI":"10.1111\/cns.14214"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.39","doi-asserted-by":"publisher","unstructured":"Cavallieri F, Fraternali A, Arnone A, et al. 18F-FDG PET findings in Parkinson's disease associated to RAB32 S71R variant[J]. <i>Parkinsonism Relat Disord<\/i>, 2025, 134: 107343.","DOI":"10.1016\/j.parkreldis.2025.107343"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.40","doi-asserted-by":"publisher","unstructured":"Lu W, Song T, Zhou Y, et al. Cranial glucose metabolic patterns across prodromal and clinical Parkinson's disease revealed by <sup>18<\/sup>F-FDG PET[J]. <i>Eur J Nucl Med Mol Imaging<\/i>, 2026, 53(2): 1211\u20131221.","DOI":"10.1007\/s00259-025-07533-3"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.41","doi-asserted-by":"publisher","unstructured":"Kim SG, Hwang JS, George NP, et al. Integrative metabolome and proteome analysis of cerebrospinal fluid in Parkinson's disease[J]. <i>Int J Mol Sci<\/i>, 2024, 25(21): 11406.","DOI":"10.3390\/ijms252111406"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.42","doi-asserted-by":"publisher","unstructured":"Borsche M, M\u00e4rtens A, H\u00f6rmann P, et al. <i>In vivo<\/i> investigation of glucose metabolism in idiopathic and <i>PRKN<\/i>-related Parkinson's disease[J]. <i>Mov Disord<\/i>, 2023, 38(4): 697\u2013702.","DOI":"10.1002\/mds.29333"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.43","doi-asserted-by":"publisher","unstructured":"Firbank MJ, Yarnall AJ, Lawson RA, et al. Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study[J]. <i>J Neurol Neurosurg Psychiatry<\/i>, 2017, 88(4): 310\u2013316.","DOI":"10.1136\/jnnp-2016-313918"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.44","doi-asserted-by":"publisher","unstructured":"Szturm T, Beheshti I, Mahana B, et al. Imaging cerebral glucose metabolism during dual-task walking in patients with Parkinson's disease[J]. <i>J Neuroimaging<\/i>, 2021, 31(2): 356\u2013362.","DOI":"10.1111\/jon.12812"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.45","doi-asserted-by":"publisher","unstructured":"Gonz\u00e1lez-Redondo R, Garc\u00eda-Garc\u00eda D, Clavero P, et al. Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: A two-step process[J]. <i>Brain<\/i>, 2014, 137(Pt 8): 2356\u20132367.","DOI":"10.1093\/brain\/awu159"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.46","doi-asserted-by":"publisher","unstructured":"Eggers C, Schwartz F, Pedrosa DJ, et al. Parkinson's disease subtypes show a specific link between dopaminergic and glucose metabolism in the striatum[J]. <i>PLoS One<\/i>, 2014, 9(5): e96629.","DOI":"10.1371\/journal.pone.0096629"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.47","doi-asserted-by":"publisher","unstructured":"Zhu Z, Geng Y, Wang X, et al. Characteristics of brain glucose metabolism in Parkinson's disease patients with freezing of gait: A study based on <sup>18<\/sup>F-FDG PET imaging and deep learning[J]. <i>BMC Neurol<\/i>, 2025, 25(1): 446.","DOI":"10.1186\/s12883-025-04468-y"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.48","doi-asserted-by":"publisher","unstructured":"Luo G, Shi X, Jiang L, et al. Effects of STN-DBS surgery on cerebral glucose metabolism and distribution of DAT in Parkinson's disease[J]. <i>Brain Behav<\/i>, 2023, 13(8): e3172.","DOI":"10.1002\/brb3.3172"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.49","doi-asserted-by":"publisher","unstructured":"Huang C, Mattis P, Tang C, et al. Metabolic brain networks associated with cognitive function in Parkinson's disease[J]. <i>Neuroimage<\/i>, 2007, 34(2): 714\u2013723.","DOI":"10.1016\/j.neuroimage.2006.09.003"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.50","doi-asserted-by":"publisher","unstructured":"Gang M, Baba T, Hosokai Y, et al. Clinical and cerebral metabolic changes in Parkinson's disease with basal forebrain atrophy[J]. <i>Mov Disord<\/i>, 2020, 35(5): 825\u2013832.","DOI":"10.1002\/mds.27988"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.51","doi-asserted-by":"publisher","unstructured":"Sun Z, Li Y, Zhao H, et al. Correlation analysis between <sup>18<\/sup>F-fluorodeoxyglucose positron emission tomography and cognitive function in first diagnosed Parkinson's disease patients[J]. <i>Front Neurol<\/i>, 2023, 14: 1195576.","DOI":"10.3389\/fneur.2023.1195576"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.52","doi-asserted-by":"publisher","unstructured":"Kamath T, Abdulraouf A, Burris SJ, et al. Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson's disease[J]. <i>Nat Neurosci<\/i>, 2022, 25(5): 588\u2013595.","DOI":"10.1038\/s41593-022-01061-1"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.53","doi-asserted-by":"publisher","unstructured":"Chen B, Zhang Q, Zhong X, et al. Dopamine modification of glycolytic enzymes impairs glycolysis: Possible implications for Parkinson's disease[J]. <i>Cell Commun Signal<\/i>, 2024, 22(1): 75.","DOI":"10.1186\/s12964-024-01478-0"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.54","doi-asserted-by":"publisher","unstructured":"Dehay B, Bourdenx M, Gorry P, et al. Targeting \u03b1-synuclein for treatment of Parkinson's disease: Mechanistic and therapeutic considerations[J]. <i>Lancet Neurol<\/i>, 2015, 14(8): 855\u2013866.","DOI":"10.1016\/S1474-4422(15)00006-X"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.55","doi-asserted-by":"publisher","unstructured":"Lim SY, Klein C. Parkinson's disease is predominantly a genetic disease[J]. <i>J Parkinsons Dis<\/i>, 2024, 14(3): 467\u2013482.","DOI":"10.3233\/JPD-230376"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.56","doi-asserted-by":"publisher","unstructured":"Qiao H, He X, Zhang Q, et al. Alpha-synuclein induces microglial migration <i>via<\/i> PKM2-dependent glycolysis[J]. <i>Int J Biol Macromol<\/i>, 2019, 129: 601\u2013607.","DOI":"10.1016\/j.ijbiomac.2019.02.029"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.57","doi-asserted-by":"publisher","unstructured":"Wang D, Gu X, Ma X, et al. Nanopolyphenol rejuvenates microglial surveillance of multiple misfolded proteins through metabolic reprogramming[J]. <i>Acta Pharm Sin B<\/i>, 2023, 13(2): 834\u2013851.","DOI":"10.1016\/j.apsb.2022.07.014"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.58","doi-asserted-by":"publisher","unstructured":"Lu J, Wang C, Cheng X, et al. A breakdown in microglial metabolic reprogramming causes internalization dysfunction of \u03b1-synuclein in a mouse model of Parkinson's disease[J]. <i>J Neuroinflammation<\/i>, 2022, 19(1): 113.","DOI":"10.1186\/s12974-022-02484-0"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.59","doi-asserted-by":"publisher","unstructured":"Cornett K, Puderbaugh A, Back O, et al. GAPDH in neuroblastoma: Functions in metabolism and survival[J]. <i>Front Oncol<\/i>, 2022, 12: 979683.","DOI":"10.3389\/fonc.2022.979683"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.60","doi-asserted-by":"publisher","unstructured":"Sirover MA. Structural analysis of glyceraldehyde-3-phosphate dehydrogenase functional diversity[J]. <i>Int J Biochem Cell Biol<\/i>, 2014, 57: 20\u201326.","DOI":"10.1016\/j.biocel.2014.09.026"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.61","doi-asserted-by":"publisher","unstructured":"Melnikova A, Pozdyshev D, Barinova K, et al. \u03b1-synuclein overexpression in SH-SY5Y human neuroblastoma cells leads to the accumulation of Thioflavin S-positive aggregates and impairment of glycolysis[J]. <i>Biochemistry (Mosc)<\/i>, 2020, 85(5): 604\u2013613.","DOI":"10.1134\/s0006297920050090"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.62","doi-asserted-by":"publisher","unstructured":"Liguori C, Stefani A, Fernandes M, et al. Biomarkers of cerebral glucose metabolism and neurodegeneration in Parkinson's disease: A cerebrospinal fluid-based study[J]. <i>J Parkinsons Dis<\/i>, 2022, 12(2): 537\u2013544.","DOI":"10.3233\/JPD-212936"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.63","doi-asserted-by":"publisher","unstructured":"Li J, Chen L, Qin Q, et al. Upregulated hexokinase 2 expression induces the apoptosis of dopaminergic neurons by promoting lactate production in Parkinson's disease[J]. <i>Neurobiol Dis<\/i>, 2022, 163: 105605.","DOI":"10.1016\/j.nbd.2021.105605"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.64","doi-asserted-by":"publisher","unstructured":"Bonifati V, Rizzu P, van Baren MJ, et al. Mutations in the <i>DJ-1<\/i> gene associated with autosomal recessive early-onset parkinsonism[J]. <i>Science<\/i>, 2003, 299(5604): 256\u2013259.","DOI":"10.1126\/science.1077209"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.65","doi-asserted-by":"publisher","unstructured":"Mencke P, Boussaad I, Romano CD, et al. The role of DJ-1 in cellular metabolism and pathophysiological implications for Parkinson's disease[J]. <i>Cells<\/i>, 2021, 10(2): 347.","DOI":"10.3390\/cells10020347"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.66","doi-asserted-by":"publisher","unstructured":"Skou LD, Johansen SK, Okarmus J, et al. Pathogenesis of DJ-1\/PARK7-mediated Parkinson's disease[J]. <i>Cells<\/i>, 2024, 13(4): 296.","DOI":"10.3390\/cells13040296"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.67","doi-asserted-by":"publisher","unstructured":"De Lazzari F, Agostini F, Plotegher N, et al. DJ-1 promotes energy balance by regulating both mitochondrial and autophagic homeostasis[J]. <i>Neurobiol Dis<\/i>, 2023, 176: 105941.","DOI":"10.1016\/j.nbd.2022.105941"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.68","doi-asserted-by":"publisher","unstructured":"Watanabe A, Ogiwara S, Saito M, et al. The reaction mechanism for glycolysis side product degradation by Parkinson's disease-linked DJ-1[J]. <i>J Cell Biol<\/i>, 2025, 224(8): e202411078.","DOI":"10.1083\/jcb.202411078"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.69","doi-asserted-by":"publisher","unstructured":"Piston D, Alvarez-Erviti L, Bansal V, et al. DJ-1 is a redox sensitive adapter protein for high molecular weight complexes involved in regulation of catecholamine homeostasis[J]. <i>Hum Mol Genet<\/i>, 2017, 26(20): 4028\u20134041.","DOI":"10.1093\/hmg\/ddx294"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.70","doi-asserted-by":"publisher","unstructured":"Solana-Manrique C, Sanz FJ, Ripoll\u00e9s E, et al. Enhanced activity of glycolytic enzymes in Drosophila and human cell models of Parkinson's disease based on DJ-1 deficiency[J]. <i>Free Radic Biol Med<\/i>, 2020, 158: 137\u2013148.","DOI":"10.1016\/j.freeradbiomed.2020.06.036"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.71","doi-asserted-by":"publisher","unstructured":"Heremans IP, Caligiore F, Gerin I, et al. Parkinson's disease protein PARK7 prevents metabolite and protein damage caused by a glycolytic metabolite[J]. <i>Proc Natl Acad Sci U S A<\/i>, 2022, 119(4): e2111338119.","DOI":"10.1073\/pnas.2111338119"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.72","doi-asserted-by":"publisher","unstructured":"Danileviciute E, Zeng N, Capelle CM, et al. PARK7\/DJ-1 promotes pyruvate dehydrogenase activity and maintains T<sub>reg<\/sub> homeostasis during ageing[J]. <i>Nat Metab<\/i>, 2022, 4(5): 589\u2013607.","DOI":"10.1038\/s42255-022-00576-y"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.73","doi-asserted-by":"publisher","unstructured":"Wang J, Zhao C, Si Y, et al. ACT and UCH-L1 polymorphisms in Parkinson's disease and age of onset[J]. <i>Mov Disord<\/i>, 2002, 17(4): 767\u2013771.","DOI":"10.1002\/mds.10179"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.74","doi-asserted-by":"publisher","unstructured":"Ham SJ, Lee D, Xu W, et al. Loss of UCHL1 rescues the defects related to Parkinson's disease by suppressing glycolysis[J]. <i>Sci Adv<\/i>, 2021, 7(28): eabg4574.","DOI":"10.1126\/sciadv.abg4574"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.75","doi-asserted-by":"publisher","unstructured":"Requejo-Aguilar R, Lopez-Fabuel I, Fernandez E, et al. PINK1 deficiency sustains cell proliferation by reprogramming glucose metabolism through HIF1[J]. <i>Nat Commun<\/i>, 2014, 5: 4514.","DOI":"10.1038\/ncomms5514"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.76","doi-asserted-by":"publisher","unstructured":"Siddique AHH, Kale PP. Importance of glucose and its metabolism in neurodegenerative disorder, as well as the combination of multiple therapeutic strategies targeting \u03b1-synuclein and neuroprotection in the treatment of Parkinson's disease[J]. <i>Rev Neurol (Paris)<\/i>, 2024, 180(8): 736\u2013753.","DOI":"10.1016\/j.neurol.2023.08.011"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.77","doi-asserted-by":"publisher","unstructured":"Morales-Brice\u00f1o H, Ha AD, London K, et al. Parkinsonism in PGK1 deficiency implicates the glycolytic pathway in nigrostriatal dysfunction[J]. <i>Parkinsonism Relat Disord<\/i>, 2019, 64: 319\u2013323.","DOI":"10.1016\/j.parkreldis.2019.04.004"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.78","doi-asserted-by":"publisher","unstructured":"Ren M, Yang Y, Heng KHY, et al. <i>MED13<\/i> and glycolysis are conserved modifiers of \u03b1-synuclein-associated neurodegeneration[J]. <i>Cell Rep<\/i>, 2022, 41(12): 111852.","DOI":"10.1016\/j.celrep.2022.111852"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.79","doi-asserted-by":"publisher","unstructured":"Nakano M, Imamura H, Sasaoka N, et al. ATP maintenance <i>via<\/i> two types of ATP regulators mitigates pathological phenotypes in mouse models of Parkinson's disease[J]. <i>eBioMedicine<\/i>, 2017, 22: 225\u2013241.","DOI":"10.1016\/j.ebiom.2017.07.024"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.80","doi-asserted-by":"publisher","unstructured":"Cai R, Zhang Y, Simmering JE, et al. Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databases[J]. <i>J Clin Invest<\/i>, 2019, 129(10): 4539\u20134549.","DOI":"10.1172\/JCI129987"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.81","doi-asserted-by":"publisher","unstructured":"Haga H, Matsuo K, Yabuki Y, et al. Enhancement of ATP production ameliorates motor and cognitive impairments in a mouse model of MPTP-induced Parkinson's disease[J]. <i>Neurochem Int<\/i>, 2019, 129: 104492.","DOI":"10.1016\/j.neuint.2019.104492"},{"key":"10.7555\/JBR.39.20250499.swyxyjzzywb.82","doi-asserted-by":"publisher","unstructured":"Hong CT, Chau KY, Schapira AHV. Meclizine-induced enhanced glycolysis is neuroprotective in Parkinson disease cell models[J]. <i>Sci Rep<\/i>, 2016, 6: 25344.","DOI":"10.1038\/srep25344"}],"container-title":["Journal of Biomedical Research"],"original-title":[],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:41:55Z","timestamp":1793601715000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jbr-pub.org.cn\/article\/doi\/10.7555\/JBR.39.20250499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"alternative-id":["JBR-2025-0499"],"URL":"https:\/\/doi.org\/10.7555\/jbr.39.20250499","relation":{},"ISSN":["1674-8301","1674-8301"],"issn-type":[{"value":"1674-8301","type":"print"},{"value":"1674-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}